MEDIFAST INC (MED) Stock Income Statement
USA - NYSE:MED - US58470H1014 - Common Stock
14.06 USD
-0.26 (-1.82%)
14.06 USD
0 (0%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 480.45M | 602.46M | 1.07B | 1.60B | 1.53B | |||
| Cost Of Goods | 125.67M | 157.84M | 296.20M | 458.20M | 398.50M | |||
| Gross Profit | 354.78M | 444.62M | 775.85M | 1.14B | 1.13B | |||
| Operating Expenses | 352.56M | 425.15M | 649.45M | 955.60M | 911.30M | |||
| Research and Development | 4.50M | 4.60M | 4.60M | 4.50M | 4.40M | |||
| Selling, General, and Administrative Expenses | 348.06M | 420.55M | 644.85M | 951.10M | 907.00M | |||
| Operating Income | 2.23M | 19.47M | 126.40M | 184.80M | 216.20M | |||
| Interest Income/Expense | 3.22M | 715.00K | 2.49M | -700.00K | -200.00K | |||
| Other Income/Expense | 811.00K | -3.90M | -95.00K | 0.00 | 100.00K | |||
| Non Recurring Items | N/A | -12.50M | N/A | N/A | N/A | |||
| Income Before Taxes | 6.25M | 3.79M | 128.80M | 184.10M | 216.10M | |||
| Income Tax | 2.62M | 1.70M | 29.38M | 40.50M | 52.10M | |||
| Net Income | 3.64M | 2.09M | 99.42M | 143.60M | 164.00M | |||
| EBITDA | 15.93M | 32.18M | 139.51M | 195.80M | 223.00M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.33 | 0.19 | 9.10 | 12.70 | 13.89 | |||
| Non GAAP EPS | 0.54 | 2.03 | 9.11 | 13.55 | 13.89 | |||
| Statistics | ||||||||
| Gross Profit Margin | 73.84% | 73.80% | 72.37% | 71.34% | 73.89% | |||
| Profit Margin | 0.76% | 0.35% | 9.27% | 8.98% | 10.75% | |||
| Operating Profit Margin | 0.46% | 3.23% | 11.79% | 11.56% | 14.17% | |||
All data in USD